UPMC   

Questions discussed in this category



If so, when? Are there certain ERBB2 mutations that would predict response to trastuzumab and/or neratinib? 

What would you choose if there is no response to neoadjuvant AC-T? Taxol, THP, TCHP?

(For instance, TCX4 instead of AC->T for smaller tumors?)Does this affect your decision about treating with neoadjuvant versus adjuvant chemotherap...


Papers discussed in this category


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-03-15

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-03-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-10

N. Engl. J. Med., 2017-07-13

Journal of the National Cancer Institute, 2010-07-07

J Natl Cancer Inst, 2006 Jul 5

J. Natl. Cancer Inst., 2010-07-07

J. Clin. Oncol., 2003-10-01

Clin. Cancer Res., 2018 Mar 26